Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 298 participants.

Also called NCT06704633

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 298 participants (planned count) (from the registry)
Sponsor
Martin Rohacek (from the registry)
Registry
  • NCT NCT06704633
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Tanzania (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06704633. Allocation not applicable; no masking; primary purpose treatment. Start 2026-06-30 (actual); primary completion 2028-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania
Condition
Heart Failure
Intervention (Drug)
Sacubitril / Valsartan Oral Tablet
Lead sponsor
Martin Rohacek (class: other)
Collaborator
Ifakara Health Institute (class: other)

Record details

Record id
cardio:ct-nct06704633
Content hash
9b5c4c4c05e8beb4f184e9700e11b19379ac52f897f81ca565a7d10f0f3a2ddc